The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Viva Leisure (VVA) has executed a binding business sale agreement to buy six Pinnacle health clubs in Victoria
  • Because of various conditions, the final consideration is unknown but will sit between $6.05 million and $6.25 million
  • Upon completion, Viva Leisure will increase its presence in Victoria from eight to 14 locations and will add another 6500 members to its register
  • The acquisition is expected to be completed in the next 60 days
  • Viva Leisure has ended the day 2.73 per cent in the red with shares trading at $2.85

Viva Leisure (VVA) has executed a binding business sale agreement to buy six Pinnacle health clubs in Victoria.

Depending on various conditions, the final consideration is unknown, but will sit between $6.05 million and $6.25 million.

This sum will be funded equally through debt and equity from a recent capital raise.

The six locations are located in Caribbean Park, Mulgrave, Oakley, Parkdale, Scoresby and Upwey.

Upon completion, Viva Leisure will increase its presence in Victoria from eight to 14 locations and will add another 6500 members to its register.

“The acquisition of Pinnacle health clubs expand on and continues to cement Viva Leisure’s position as a leading and fast-growing health club owner and operator in the Australian market,” CEO and Managing Director Harry Konstantinou commented.

“In addition, the acquisition will strengthen and double Viva Leisure’s Victorian metropolitan presence and will provide further synergies such as marketing,” he said.

“The Pinnacle business is a highly complementary business to Viva Leisure and provides attractive membership options which could be rolled out through the rest of the Viva Leisure network,” he added.

The acquisition should finalise in the next 60 days.

Viva Leisure has ended the day 2.73 per cent in the red with shares trading at $2.85 in a $240.1 million market cap.

VVA by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…